Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients

被引：2
|
作者：
Wang, Ji-Gan [1 ]
Chen, Rui [1 ]
Wang, Li-Chuan [1 ]
机构：
[1] Maternal & Child Hlth Hosp Guangxi Zhuang Autonom, Nanning, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 09期
关键词：
HEPATOCELLULAR-CARCINOMA; VIRAL LOAD; MORTALITY; RISK; HBV;
D O I：
10.1111/apt.16323
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1048 / 1049
页数：2
相关论文
共 50 条
  • [1] Tenofovir is Superior to Entecavir in Patients with Treatment-naive Hepatitis B e-Antigen-Positive Chronic Hepatitis B
    Behera, Manas K.
    Pati, Girish K.
    Narayan, Jimmy
    Mishra, Debakanta
    Meher, Lalit K.
    Singh, Ayaskant
    Uthansingh, Kanishka
    Sahu, Manoj K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (01) : 37 - 44
  • [2] Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naive Chronic Hepatitis B Patients
    Yu, Hyung Min
    Kwon, So Young
    Kim, Jiwan
    Chung, Hyun Ah
    Kwon, Se Woong
    Jeong, Taek Gun
    An, Sang Hee
    Jeong, Gyung Won
    Yun, Seon Ung
    Min, Jae Ki
    Kim, Jeong Han
    Choe, Won Hyeok
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (03) : 146 - 151
  • [3] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Hye Yeon Chon
    Sang Hoon Ahn
    Yoon Jun Kim
    Jung-Hwan Yoon
    Jeong-Hoon Lee
    Dong Hyun Sinn
    Seung Up Kim
    Hepatology International, 2021, 15 : 1328 - 1336
  • [4] A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea
    Kim, Seung Up
    Seo, Yeon Seok
    Lee, Han Ah
    Kim, Mi Na
    Lee, Yu Rim
    Lee, Hye Won
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Han, Kwang-Hyub
    Hwang, Seong Gyu
    Rim, Kyu Sung
    Um, Soon Ho
    Tak, Won Young
    Kweon, Young Oh
    Kim, Beom Kyung
    Park, Soo Young
    JOURNAL OF HEPATOLOGY, 2019, 71 (03) : 456 - 464
  • [5] Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
    Chon, Hye Yeon
    Ahn, Sang Hoon
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    HEPATOLOGY INTERNATIONAL, 2021, 15 (06) : 1328 - 1336
  • [6] Entecavir versus Tenofovir for the Prevention of Hepatocellular Carcinoma in Treatment-naive Chronic Hepatitis B Patients in Korea
    Choi, HeeKyoung
    Seo, Gi Hyeon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (14) : 1 - 10
  • [7] Mortality, liver transplantation and hepatic complications in patients with treatment-naive chronic hepatitis B treated with entecavir vs tenofovir
    Kim, Byung Gyu
    Park, Neung Hwa
    Lee, Seung Bum
    Lee, Hojune
    Lee, Byung Uk
    Park, Jae Ho
    Jung, Seok Won
    Jeong, In Du
    Bang, Sung-Jo
    Shin, Jung Woo
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (12) : 1565 - 1575
  • [8] Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
    Yu, Jung Hwan
    Suh, Young Ju
    Jin, Young-Joo
    Heo, Nae-Yun
    Jang, Ji Woong
    You, Chan Ran
    An, Hyun Young
    Lee, Jin-Woo
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (07) : 865 - 872
  • [9] Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study
    Batirel, Ayse
    Guclu, Ertugrul
    Arslan, Ferhat
    Kocak, Funda
    Karabay, Oguz
    Ozer, Serdar
    Turanli, Munevver
    Mert, Ali
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 28 : 153 - 159
  • [10] Randomized prospective study showing the non-inferiority of tenofovir to entecavir in treatment-naive chronic hepatitis B patients
    Koike, Kazuhiko
    Suyama, Kazuaki
    Ito, Hiroshi
    Itoh, Hiroshi
    Sugiura, Wataru
    HEPATOLOGY RESEARCH, 2018, 48 (01) : 59 - 68
12345